BELIEF Trial
Laufzeit: 01.01.2009 - 31.12.2012
imported
Kurzfassung
A Multicenter, Open–Label Trial of Belinostat in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
Laufzeit: 01.01.2009 - 31.12.2012
A Multicenter, Open–Label Trial of Belinostat in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma